URL has been copied successfully!
Sunshine Biopharma Inc. (NASDAQ:SBFM) stock fell in Tuesday premarket trading, likely pressured by dilution concerns after the company announced the pricing of a $6 million public offering late Monday.
Public Offering Priced
The pharmaceutical company said the offering includes 12 million common units, or pre-funded units, priced at $0.50 each. Each unit consists of one share of common stock, or one pre-funded warrant, along with two Series C warrants to purchase additional shares at an exercise price of $0.50.
The Series C warrants will be exercisable immediately and …
Please follow us:
This post was originally published here
